Final analysis showed that , out of 135 patients in ITT ( DB ) population , 71 ( 52.6 % ) had a relapse event , 45 ( 33.3 % ) were ongoing at the time the study was stopped , and 19 ( 14.1 % ) discontinued from the DB phase .